thymidine has been researched along with Myasthenia Gravis in 5 studies
Myasthenia Gravis: A disorder of neuromuscular transmission characterized by fatigable weakness of cranial and skeletal muscles with elevated titers of ACETYLCHOLINE RECEPTORS or muscle-specific receptor tyrosine kinase (MuSK) autoantibodies. Clinical manifestations may include ocular muscle weakness (fluctuating, asymmetric, external ophthalmoplegia; diplopia; ptosis; and weakness of eye closure) and extraocular fatigable weakness of facial, bulbar, respiratory, and proximal limb muscles. The disease may remain limited to the ocular muscles (ocular myasthenia). THYMOMA is commonly associated with this condition.
| Excerpt | Relevance | Reference |
|---|---|---|
| "The anti-rheumatoid drug D-penicillamine (D-pen) has a reactive sulfhydryl group capable of modifying self antigens, and can provoke typical autoantibody-mediated myasthenia gravis (MG), especially in DR1+ individuals." | 7.70 | T cell responses to D-penicillamine in drug-induced myasthenia gravis: recognition of modified DR1:peptide complexes. ( Hill, M; Moss, P; Newsom-Davis, J; Willcox, N; Wordsworth, P, 1999) |
| "The anti-rheumatoid drug D-penicillamine (D-pen) has a reactive sulfhydryl group capable of modifying self antigens, and can provoke typical autoantibody-mediated myasthenia gravis (MG), especially in DR1+ individuals." | 3.70 | T cell responses to D-penicillamine in drug-induced myasthenia gravis: recognition of modified DR1:peptide complexes. ( Hill, M; Moss, P; Newsom-Davis, J; Willcox, N; Wordsworth, P, 1999) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 4 (80.00) | 18.7374 |
| 1990's | 1 (20.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Piga, A | 1 |
| Ganeshaguru, K | 1 |
| Lee, N | 1 |
| Breatnach, F | 1 |
| Prentice, HG | 1 |
| Hoffbrand, AV | 1 |
| Hill, M | 1 |
| Moss, P | 1 |
| Wordsworth, P | 1 |
| Newsom-Davis, J | 1 |
| Willcox, N | 1 |
| Rodey, GE | 1 |
| Davis, T | 1 |
| Quie, PG | 1 |
| Knight, S | 1 |
| Bradley, J | 1 |
| Oppenheim, JJ | 2 |
| Ling, NR | 1 |
| Goldstein, G | 1 |
5 other studies available for thymidine and Myasthenia Gravis
| Article | Year |
|---|---|
DNA synthesis in thymic-acute lymphoblastic leukaemia.
Topics: Bone Marrow; Deoxycytidine; Deoxyribonucleosides; DNA; DNA, Neoplasm; Humans; Leukemia, Lymphoid; Le | 1981 |
T cell responses to D-penicillamine in drug-induced myasthenia gravis: recognition of modified DR1:peptide complexes.
Topics: Aged; Amino Acid Sequence; Antirheumatic Agents; Autoimmune Diseases; Base Sequence; Blood Proteins; | 1999 |
Response of peripheral blood lymphocytes from normal, hypogammaglobulinemic and chronic lymphocytic leukemic patients.
Topics: Agammaglobulinemia; Bacterial Proteins; Cell Adhesion; Cells, Cultured; Chromatography, DEAE-Cellulo | 1972 |
The in vitro transformation of thymocytes and lymphocytes from humans, rabbits and guinea-pigs and from thymomas.
Topics: Adult; Agammaglobulinemia; Animals; Blood Cells; Cell Biology; Diphtheria Antitoxin; DNA; Female; Gu | 1968 |
Enhanced thymic lymphocyte response to phytohaemagglutinin in experimental autoimmune thymitis.
Topics: Animals; Antigen-Antibody Reactions; Autoimmune Diseases; Culture Techniques; Guinea Pigs; Inflammat | 1969 |